These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
275 related items for PubMed ID: 25720064
1. Antinociceptive effects of FTY720 during trauma-induced neuropathic pain are mediated by spinal S1P receptors. Zhang DD, Linke B, Suo J, Zivkovic A, Schreiber Y, Ferreirós N, Henke M, Geisslinger G, Stark H, Scholich K. Biol Chem; 2015 Jun; 396(6-7):783-94. PubMed ID: 25720064 [Abstract] [Full Text] [Related]
2. Regulation of endothelial nitric oxide synthase activation in endothelial cells by S1P1 and S1P3. Tölle M, Klöckl L, Wiedon A, Zidek W, van der Giet M, Schuchardt M. Biochem Biophys Res Commun; 2016 Aug 05; 476(4):627-634. PubMed ID: 27282481 [Abstract] [Full Text] [Related]
3. The development and maintenance of paclitaxel-induced neuropathic pain require activation of the sphingosine 1-phosphate receptor subtype 1. Janes K, Little JW, Li C, Bryant L, Chen C, Chen Z, Kamocki K, Doyle T, Snider A, Esposito E, Cuzzocrea S, Bieberich E, Obeid L, Petrache I, Nicol G, Neumann WL, Salvemini D. J Biol Chem; 2014 Jul 25; 289(30):21082-97. PubMed ID: 24876379 [Abstract] [Full Text] [Related]
4. Testosterone regulates the expression and functional activity of sphingosine-1-phosphate receptors in the rat corpus cavernosum. Yin J, Guo YM, Chen P, Xiao H, Wang XH, DiSanto ME, Zhang XH. J Cell Mol Med; 2018 Mar 25; 22(3):1507-1516. PubMed ID: 29266713 [Abstract] [Full Text] [Related]
5. FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system. Brinkmann V. Br J Pharmacol; 2009 Nov 25; 158(5):1173-82. PubMed ID: 19814729 [Abstract] [Full Text] [Related]
10. Dissociation between the anti-allodynic effects of fingolimod (FTY720) and desensitization of S1P1 receptor-mediated G-protein activation in a mouse model of sciatic nerve injury. Pondelick AM, Moncayo LV, Donvito G, McLane VD, Gillespie JC, Hauser KF, Spiegel S, Lichtman AH, Sim-Selley LJ, Selley DE. Neuropharmacology; 2024 Dec 15; 261():110165. PubMed ID: 39303855 [Abstract] [Full Text] [Related]
11. Sphingosine-1-phosphate-induced airway hyper-reactivity in rodents is mediated by the sphingosine-1-phosphate type 3 receptor. Trifilieff A, Fozard JR. J Pharmacol Exp Ther; 2012 Aug 15; 342(2):399-406. PubMed ID: 22570366 [Abstract] [Full Text] [Related]
15. Neurological S1P signaling as an emerging mechanism of action of oral FTY720 (fingolimod) in multiple sclerosis. Lee CW, Choi JW, Chun J. Arch Pharm Res; 2010 Oct 15; 33(10):1567-74. PubMed ID: 21052934 [Abstract] [Full Text] [Related]
16. New players on the center stage: sphingosine 1-phosphate and its receptors as drug targets. Huwiler A, Pfeilschifter J. Biochem Pharmacol; 2008 May 15; 75(10):1893-900. PubMed ID: 18321471 [Abstract] [Full Text] [Related]
18. Non-phosphorylated FTY720 induces apoptosis of human microglia by activating SREBP2. Yoshino T, Tabunoki H, Sugiyama S, Ishii K, Kim SU, Satoh J. Cell Mol Neurobiol; 2011 Oct 15; 31(7):1009-20. PubMed ID: 21519925 [Abstract] [Full Text] [Related]
19. Fingolimod targeting protein phosphatase 2A differently affects IL-33 induced IL-2 and IFN-γ production in CD8(+) lymphocytes. Ottenlinger F, Schwiebs A, Pfarr K, Wagner A, Grüner S, Mayer CA, Pfeilschifter JM, Radeke HH. Eur J Immunol; 2016 Apr 15; 46(4):941-51. PubMed ID: 26683421 [Abstract] [Full Text] [Related]
20. Endothelial lipase is a critical determinant of high-density lipoprotein-stimulated sphingosine 1-phosphate-dependent signaling in vascular endothelium. Tatematsu S, Francis SA, Natarajan P, Rader DJ, Saghatelian A, Brown JD, Michel T, Plutzky J. Arterioscler Thromb Vasc Biol; 2013 Aug 15; 33(8):1788-94. PubMed ID: 23723371 [Abstract] [Full Text] [Related] Page: [Next] [New Search]